The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.42

Today's change+0.01 +0.18%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

China Cord Blood Corp

NYSE: CO
Last

(U.S.) $5.42

Today's change+0.01 +0.18%
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.

China Cord Blood Corp up (U.S.)$0.01

China Cord Blood Corp closed up Wednesday by (U.S.)$0.01 or 0.18% to (U.S.)$5.42. Over the last five days, shares have lost 1.99% and sit 2.07% above their 52-week low. This security has underperformed the S&P 500 by 8.34% during the last year.

Key company metrics

  • Open(U.S.) $5.49
  • Previous close(U.S.) $5.41
  • High(U.S.) $5.49
  • Low(U.S.) $5.38
  • Bid / Ask(U.S.) $5.32 / (U.S.) $6.10
  • YTD % change-14.91%
  • Volume54,175
  • Average volume (10-day)20,731
  • Average volume (1-month)39,920
  • Average volume (3-month)39,107
  • 52-week range(U.S.) $5.31 to (U.S.) $7.69
  • Beta0.56
  • Trailing P/E28.83×
  • P/E 1 year forward31.88×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.19
Updated July 27 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue169171165163
Total other revenue--------
Total revenue169171165163
Gross profit133134129129
Total cost of revenue36373734
Total operating expense119127117113
Selling / general / administrative80807876
Research & development3223
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--8----
Other operating expenses, total--------
Operating income51444850
Interest income (expense), net non-operating-28-26-26-25
Gain (loss) on sale of assets--------
Other--------
Income before tax64322829
Income after tax51191317
Income tax, total14131512
Net income50191417
Total adjustments to net income-------8
Net income before extra. items50191417
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items5019149
Inc. avail. to common incl. extra. items5019149
Diluted net income5019149
Dilution adjustment--------
Diluted weighted average shares73737373
Diluted EPS excluding extraordinary itemsvalue per share0.690.260.190.12
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.690.320.190.12